Exporter

EN
FR
Methylprednisolone
Statut de médicament essentiel
Description générale

INN
Methylprednisolone
Codes ATC
H02AB04
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2011 (TRS 965) pour Lymphoid leukaemia, not elsewhere classified
Wikipédia
Methylprednisolone
DrugBank
Methylprednisolone
Recommandations
Section
Hormones and antihormones
  • Parenteral > General injections > IV: 40 mg in vial (as sodium succinate) powder for injection; 125 mg in vial (as sodium succinate) powder for injection
  • Parenteral > General injections > IV: 40 mg in vial (as sodium succinate); 125 mg in vial (as sodium succinate)
Indications
Lymphoid leukaemia, not elsewhere classified Burkitt lymphoma including Burkitt leukaemia